Key Insights
The Antimicrobial Resistance Surveillance Market is experiencing robust growth, projected to reach \$5.90 billion in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 5.70% from 2025 to 2033. This expansion is driven by several factors. The rising prevalence of antibiotic-resistant infections globally poses a significant threat to public health, necessitating advanced surveillance systems. Increased government funding for research and development of new diagnostic tools and technologies further fuels market growth. Technological advancements, such as the development of rapid diagnostic tests and sophisticated data analytics platforms for improved epidemiological tracking, are streamlining surveillance efforts and enhancing accuracy. Furthermore, the growing adoption of point-of-care diagnostics in hospitals and clinics contributes to faster detection and treatment, thus reducing the spread of resistant pathogens. The market is segmented by solution (kits, systems, software, services), application (clinical diagnostics, public health surveillance), and end-user (hospitals, diagnostic centers). North America currently holds a significant market share due to advanced healthcare infrastructure and high adoption rates of advanced technologies. However, Asia Pacific is poised for significant growth, driven by increasing healthcare expenditure and rising infectious disease burden in developing economies.
The market's growth is, however, subject to certain restraints. High costs associated with advanced diagnostic technologies and the complexity of implementing comprehensive surveillance programs can pose challenges, particularly in resource-limited settings. Furthermore, data privacy concerns and the need for standardized data reporting protocols across different regions remain obstacles to achieving fully integrated and effective surveillance. Despite these challenges, the long-term outlook for the Antimicrobial Resistance Surveillance Market remains positive, driven by ongoing technological advancements, increased awareness of the threat of antimicrobial resistance, and the growing commitment from global health organizations and governments to combat this critical public health issue. The competitive landscape includes major players such as Becton Dickinson, Biomerieux, Cepheid, and others, constantly innovating and expanding their product portfolios to cater to the evolving needs of the market.

Antimicrobial Resistance Surveillance Market: A Comprehensive Report (2019-2033)
This detailed report provides a comprehensive analysis of the global Antimicrobial Resistance Surveillance Market, offering invaluable insights for stakeholders across the healthcare and diagnostics industries. The study period covers 2019-2033, with 2025 as the base and estimated year, and a forecast period of 2025-2033. The market is segmented by solution (Kits, Systems, Surveillance Software, Surveillance Services), application (Clinical Diagnostics, Public Health Surveillance, Other Applications), and end-user (Hospitals and Clinics, Diagnostic Centers, Other End-Users). Key players analyzed include Becton Dickinson and Company, Biomerieux, Cepheid, Bruker, SyntBioLab INC, DiaSorin S p A, Qiagen, Merck KgaA, Accelerate Diagnostics Inc, Thermo Fisher Scientific, Bio-Rad, Liofilchem S.r.l, and Pfizer Inc. The report projects a market value of xx Million by 2033, exhibiting a CAGR of xx% during the forecast period.
Antimicrobial Resistance Surveillance Market Market Structure & Competitive Dynamics
The Antimicrobial Resistance Surveillance Market is characterized by a moderately concentrated structure, with a few major players holding significant market share. The market's competitive landscape is dynamic, driven by continuous innovation in diagnostic technologies, evolving regulatory frameworks, and strategic mergers and acquisitions (M&A) activities.
Becton Dickinson and Company, Biomerieux, and Thermo Fisher Scientific currently hold the largest market shares, estimated at xx%, xx%, and xx% respectively in 2025, leveraging their established brand reputation and extensive distribution networks. Smaller players focus on niche segments or specialized technologies to compete effectively. The high cost of developing and validating new diagnostic tests creates a significant barrier to entry, limiting the number of new entrants.
Innovation ecosystems are flourishing, with collaborative partnerships between diagnostics companies, research institutions, and government agencies driving the development of advanced antimicrobial resistance detection technologies. Regulatory frameworks, particularly those related to in-vitro diagnostics (IVDs), significantly impact market access and product development timelines. The market also witnesses increasing regulatory scrutiny concerning data privacy and security associated with the collection and analysis of patient data. The substitution of older technologies with more advanced, rapid diagnostic tools is an ongoing process, pushing the market towards higher accuracy and efficiency. The trend of consolidation, evident in recent M&A activities, is expected to further shape the market structure. Major deals over the past five years have totaled an estimated xx Million, primarily focusing on expanding product portfolios and strengthening market presence.
Antimicrobial Resistance Surveillance Market Industry Trends & Insights
The global Antimicrobial Resistance Surveillance Market is experiencing robust growth, driven by the escalating prevalence of antimicrobial-resistant infections, increasing healthcare spending, and advancements in diagnostic technologies. The market's growth is further fueled by rising government initiatives focused on combating antimicrobial resistance (AMR) and improving public health surveillance systems. The rising adoption of advanced molecular diagnostic techniques, such as PCR and next-generation sequencing, is significantly improving the accuracy and speed of resistance detection. The integration of digital technologies like AI and machine learning is enhancing data analysis and predictive capabilities, allowing for more effective surveillance and outbreak management.
Consumer preferences are shifting towards rapid, point-of-care diagnostics that provide immediate results, enabling timely treatment decisions. This is driving the growth of portable and user-friendly diagnostic systems. The competitive dynamics are largely influenced by technological innovation, regulatory approvals, and pricing strategies. The market displays a strong trend towards outsourcing of surveillance services, particularly among smaller hospitals and clinics, leading to partnerships and collaborations between diagnostic providers and healthcare institutions. The market penetration of advanced molecular diagnostic technologies for AMR surveillance is projected to reach xx% by 2033, growing from xx% in 2025, indicative of significant market expansion.

Dominant Markets & Segments in Antimicrobial Resistance Surveillance Market
North America currently dominates the Antimicrobial Resistance Surveillance Market, driven by high healthcare expenditure, robust research infrastructure, and the early adoption of advanced technologies. Within this region, the United States holds the largest market share due to the high prevalence of antimicrobial-resistant infections and the substantial investment in diagnostic capabilities.
- Key Drivers for North American Dominance:
- High healthcare expenditure and insurance coverage
- Well-established healthcare infrastructure
- Significant investment in research and development
- Stringent regulatory frameworks promoting innovation
Europe is another significant market, exhibiting considerable growth due to increasing awareness of AMR and rising government funding for surveillance programs. The Asia-Pacific region is projected to experience the fastest growth rate during the forecast period, driven by rising healthcare expenditure, improving healthcare infrastructure, and increasing incidence of infectious diseases.
- By Solution: Systems segment holds the largest market share due to its comprehensive capabilities. The Surveillance Software segment is experiencing rapid growth due to advancements in data analytics and predictive modeling.
- By Application: Clinical Diagnostics accounts for the largest share, followed by Public Health Surveillance, due to the critical need for timely and accurate resistance detection in clinical settings and for broader epidemiological monitoring.
- By End-User: Hospitals and Clinics dominate the market owing to their high volume of patient samples and need for rapid diagnostic services.
Antimicrobial Resistance Surveillance Market Product Innovations
Recent years have witnessed significant advancements in antimicrobial resistance surveillance technologies. The integration of artificial intelligence and machine learning into diagnostic platforms is improving the accuracy and speed of resistance detection, enabling faster treatment decisions. The development of novel point-of-care diagnostics is expanding access to testing in resource-limited settings. Miniaturized systems are enhancing portability and ease of use, particularly crucial for field epidemiology and resource-constrained settings. These innovations are creating competitive advantages for companies that can develop and market these advanced solutions. The market is witnessing a shift towards faster, more accurate, and user-friendly systems, driving growth.
Report Segmentation & Scope
The report segments the Antimicrobial Resistance Surveillance Market by solution, application, and end-user.
By Solution: The market is segmented into kits, systems, surveillance software, and surveillance services. Each segment’s growth projection, market size, and competitive dynamics are analyzed, highlighting the increasing adoption of integrated systems and software solutions.
By Application: The report details the market size and growth prospects for clinical diagnostics, public health surveillance, and other applications, emphasizing the importance of each in combating antimicrobial resistance.
By End-User: The market is segmented into hospitals and clinics, diagnostic centers, and other end-users. The report analyzes the unique needs and preferences of each segment, highlighting the driving forces behind growth.
Key Drivers of Antimicrobial Resistance Surveillance Market Growth
Several factors contribute to the growth of the Antimicrobial Resistance Surveillance Market. The increasing prevalence of drug-resistant infections poses a significant global health threat, necessitating enhanced surveillance efforts. Government initiatives and funding for AMR research and surveillance programs are bolstering market expansion. Advances in diagnostic technologies, such as rapid molecular diagnostic assays, are improving the speed and accuracy of resistance detection. The rising adoption of data analytics and predictive modeling tools enhances surveillance capabilities, creating substantial growth potential.
Challenges in the Antimicrobial Resistance Surveillance Market Sector
Despite considerable growth opportunities, the Antimicrobial Resistance Surveillance Market faces several challenges. The high cost of advanced diagnostic technologies can limit access in resource-limited settings. Regulatory hurdles and lengthy approval processes for new diagnostic devices can impede market entry and expansion. The complexity of data integration across different healthcare systems can hinder effective surveillance. Maintaining data security and privacy is also a major concern. Finally, intense competition among established players and emerging companies also impacts profitability.
Leading Players in the Antimicrobial Resistance Surveillance Market Market
- Becton Dickinson and Company
- Biomerieux
- Cepheid
- Bruker
- SyntBioLab INC
- DiaSorin S p A
- Qiagen
- Merck KgaA
- Accelerate Diagnostics Inc
- Thermo Fisher Scientific
- Bio-Rad
- Liofilchem S.r.l
- Pfizer Inc
Key Developments in Antimicrobial Resistance Surveillance Market Sector
- January 2023: Becton Dickinson and Company launched a new rapid diagnostic test for detecting carbapenem-resistant Enterobacteriaceae.
- March 2022: Biomerieux acquired a smaller diagnostics company specializing in rapid AMR detection.
- June 2021: Thermo Fisher Scientific announced a partnership with a research institution to develop a novel AI-powered AMR surveillance platform.
- September 2020: Cepheid received FDA approval for its new molecular diagnostic assay for detecting multi-drug resistant tuberculosis. (Further updates can be added here as needed).
Strategic Antimicrobial Resistance Surveillance Market Market Outlook
The future of the Antimicrobial Resistance Surveillance Market is promising, driven by continued technological innovation and increasing global awareness of the threat of antimicrobial resistance. Strategic opportunities exist for companies focused on developing and commercializing next-generation diagnostic technologies, particularly those incorporating AI and machine learning for enhanced data analysis. Partnerships between diagnostics companies, healthcare providers, and public health agencies will play a critical role in expanding access to timely and effective AMR surveillance. The integration of digital technologies and the development of more portable and user-friendly diagnostics promise to reshape the market, creating both opportunities and challenges for existing players and new entrants.
Antimicrobial Resistance Surveillance Market Segmentation
-
1. Solution
- 1.1. Kits
- 1.2. System
- 1.3. Surveillance Software
- 1.4. Surveillance Service
-
2. Application
- 2.1. Clinical Diagnostics
- 2.2. Public Health Surveillance
- 2.3. Other Applications
-
3. End-User
- 3.1. Hospitals and Clinics
- 3.2. Diagnostic Centers
- 3.3. Other End-Users
Antimicrobial Resistance Surveillance Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Antimicrobial Resistance Surveillance Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.70% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Infections Caused by Drug-resistance Microbes; Rising Initiatives by Governments to Tackle Infectious Diseases; Emerging of Multi-Drug Resistance Due to Drug Abuse
- 3.3. Market Restrains
- 3.3.1. Higher Costs of Antimicrobial Resistance Surveillance systems and kits
- 3.4. Market Trends
- 3.4.1. The Clinical Diagnostics Under Application Segment is Expected to Hold a Significant Share in the Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Solution
- 5.1.1. Kits
- 5.1.2. System
- 5.1.3. Surveillance Software
- 5.1.4. Surveillance Service
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Clinical Diagnostics
- 5.2.2. Public Health Surveillance
- 5.2.3. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by End-User
- 5.3.1. Hospitals and Clinics
- 5.3.2. Diagnostic Centers
- 5.3.3. Other End-Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Solution
- 6. North America Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Solution
- 6.1.1. Kits
- 6.1.2. System
- 6.1.3. Surveillance Software
- 6.1.4. Surveillance Service
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Clinical Diagnostics
- 6.2.2. Public Health Surveillance
- 6.2.3. Other Applications
- 6.3. Market Analysis, Insights and Forecast - by End-User
- 6.3.1. Hospitals and Clinics
- 6.3.2. Diagnostic Centers
- 6.3.3. Other End-Users
- 6.1. Market Analysis, Insights and Forecast - by Solution
- 7. Europe Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Solution
- 7.1.1. Kits
- 7.1.2. System
- 7.1.3. Surveillance Software
- 7.1.4. Surveillance Service
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Clinical Diagnostics
- 7.2.2. Public Health Surveillance
- 7.2.3. Other Applications
- 7.3. Market Analysis, Insights and Forecast - by End-User
- 7.3.1. Hospitals and Clinics
- 7.3.2. Diagnostic Centers
- 7.3.3. Other End-Users
- 7.1. Market Analysis, Insights and Forecast - by Solution
- 8. Asia Pacific Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Solution
- 8.1.1. Kits
- 8.1.2. System
- 8.1.3. Surveillance Software
- 8.1.4. Surveillance Service
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Clinical Diagnostics
- 8.2.2. Public Health Surveillance
- 8.2.3. Other Applications
- 8.3. Market Analysis, Insights and Forecast - by End-User
- 8.3.1. Hospitals and Clinics
- 8.3.2. Diagnostic Centers
- 8.3.3. Other End-Users
- 8.1. Market Analysis, Insights and Forecast - by Solution
- 9. Middle East and Africa Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Solution
- 9.1.1. Kits
- 9.1.2. System
- 9.1.3. Surveillance Software
- 9.1.4. Surveillance Service
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Clinical Diagnostics
- 9.2.2. Public Health Surveillance
- 9.2.3. Other Applications
- 9.3. Market Analysis, Insights and Forecast - by End-User
- 9.3.1. Hospitals and Clinics
- 9.3.2. Diagnostic Centers
- 9.3.3. Other End-Users
- 9.1. Market Analysis, Insights and Forecast - by Solution
- 10. South America Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Solution
- 10.1.1. Kits
- 10.1.2. System
- 10.1.3. Surveillance Software
- 10.1.4. Surveillance Service
- 10.2. Market Analysis, Insights and Forecast - by Application
- 10.2.1. Clinical Diagnostics
- 10.2.2. Public Health Surveillance
- 10.2.3. Other Applications
- 10.3. Market Analysis, Insights and Forecast - by End-User
- 10.3.1. Hospitals and Clinics
- 10.3.2. Diagnostic Centers
- 10.3.3. Other End-Users
- 10.1. Market Analysis, Insights and Forecast - by Solution
- 11. North America Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Europe Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 Germany
- 12.1.2 United Kingdom
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Rest of Europe
- 13. Asia Pacific Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 Australia
- 13.1.5 South Korea
- 13.1.6 Rest of Asia Pacific
- 14. Middle East and Africa Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 GCC
- 14.1.2 South Africa
- 14.1.3 Rest of Middle East and Africa
- 15. South America Antimicrobial Resistance Surveillance Market Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Becton Dickinson and Company
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Biomerieux
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Cepheid
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Bruker
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 SyntBioLab INC
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 DiaSorin S p A
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Qiagen*List Not Exhaustive
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Merck KgaA
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Accelerate Diagnostics In
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Thermo Fisher Scientific
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 Bio-Rad
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.12 Liofilchem S r l
- 16.2.12.1. Overview
- 16.2.12.2. Products
- 16.2.12.3. SWOT Analysis
- 16.2.12.4. Recent Developments
- 16.2.12.5. Financials (Based on Availability)
- 16.2.13 Pfizer Inc
- 16.2.13.1. Overview
- 16.2.13.2. Products
- 16.2.13.3. SWOT Analysis
- 16.2.13.4. Recent Developments
- 16.2.13.5. Financials (Based on Availability)
- 16.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: Global Antimicrobial Resistance Surveillance Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: North America Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 3: North America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 4: Europe Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 5: Europe Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 7: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 8: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 9: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 11: South America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 12: North America Antimicrobial Resistance Surveillance Market Revenue (Million), by Solution 2024 & 2032
- Figure 13: North America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 14: North America Antimicrobial Resistance Surveillance Market Revenue (Million), by Application 2024 & 2032
- Figure 15: North America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Application 2024 & 2032
- Figure 16: North America Antimicrobial Resistance Surveillance Market Revenue (Million), by End-User 2024 & 2032
- Figure 17: North America Antimicrobial Resistance Surveillance Market Revenue Share (%), by End-User 2024 & 2032
- Figure 18: North America Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 19: North America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 20: Europe Antimicrobial Resistance Surveillance Market Revenue (Million), by Solution 2024 & 2032
- Figure 21: Europe Antimicrobial Resistance Surveillance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 22: Europe Antimicrobial Resistance Surveillance Market Revenue (Million), by Application 2024 & 2032
- Figure 23: Europe Antimicrobial Resistance Surveillance Market Revenue Share (%), by Application 2024 & 2032
- Figure 24: Europe Antimicrobial Resistance Surveillance Market Revenue (Million), by End-User 2024 & 2032
- Figure 25: Europe Antimicrobial Resistance Surveillance Market Revenue Share (%), by End-User 2024 & 2032
- Figure 26: Europe Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 27: Europe Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue (Million), by Solution 2024 & 2032
- Figure 29: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 30: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue (Million), by Application 2024 & 2032
- Figure 31: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue Share (%), by Application 2024 & 2032
- Figure 32: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue (Million), by End-User 2024 & 2032
- Figure 33: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue Share (%), by End-User 2024 & 2032
- Figure 34: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 35: Asia Pacific Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 36: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue (Million), by Solution 2024 & 2032
- Figure 37: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 38: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue (Million), by Application 2024 & 2032
- Figure 39: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue Share (%), by Application 2024 & 2032
- Figure 40: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue (Million), by End-User 2024 & 2032
- Figure 41: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue Share (%), by End-User 2024 & 2032
- Figure 42: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 43: Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
- Figure 44: South America Antimicrobial Resistance Surveillance Market Revenue (Million), by Solution 2024 & 2032
- Figure 45: South America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Solution 2024 & 2032
- Figure 46: South America Antimicrobial Resistance Surveillance Market Revenue (Million), by Application 2024 & 2032
- Figure 47: South America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Application 2024 & 2032
- Figure 48: South America Antimicrobial Resistance Surveillance Market Revenue (Million), by End-User 2024 & 2032
- Figure 49: South America Antimicrobial Resistance Surveillance Market Revenue Share (%), by End-User 2024 & 2032
- Figure 50: South America Antimicrobial Resistance Surveillance Market Revenue (Million), by Country 2024 & 2032
- Figure 51: South America Antimicrobial Resistance Surveillance Market Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 3: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Application 2019 & 2032
- Table 4: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by End-User 2019 & 2032
- Table 5: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 7: United States Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Canada Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Mexico Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 11: Germany Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: United Kingdom Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: France Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Italy Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 15: Spain Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Rest of Europe Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: China Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Japan Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: India Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Australia Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: South Korea Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Rest of Asia Pacific Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 25: GCC Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: South Africa Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Rest of Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 29: Brazil Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Argentina Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 31: Rest of South America Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 33: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Application 2019 & 2032
- Table 34: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by End-User 2019 & 2032
- Table 35: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 36: United States Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: Canada Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Mexico Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 40: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Application 2019 & 2032
- Table 41: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by End-User 2019 & 2032
- Table 42: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 43: Germany Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: United Kingdom Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: France Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: Italy Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 47: Spain Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: Rest of Europe Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 49: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 50: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Application 2019 & 2032
- Table 51: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by End-User 2019 & 2032
- Table 52: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 53: China Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: Japan Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 55: India Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Australia Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 57: South Korea Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Rest of Asia Pacific Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 59: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 60: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Application 2019 & 2032
- Table 61: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by End-User 2019 & 2032
- Table 62: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 63: GCC Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: South Africa Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 65: Rest of Middle East and Africa Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 66: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Solution 2019 & 2032
- Table 67: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Application 2019 & 2032
- Table 68: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by End-User 2019 & 2032
- Table 69: Global Antimicrobial Resistance Surveillance Market Revenue Million Forecast, by Country 2019 & 2032
- Table 70: Brazil Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 71: Argentina Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 72: Rest of South America Antimicrobial Resistance Surveillance Market Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Antimicrobial Resistance Surveillance Market?
The projected CAGR is approximately 5.70%.
2. Which companies are prominent players in the Antimicrobial Resistance Surveillance Market?
Key companies in the market include Becton Dickinson and Company, Biomerieux, Cepheid, Bruker, SyntBioLab INC, DiaSorin S p A, Qiagen*List Not Exhaustive, Merck KgaA, Accelerate Diagnostics In, Thermo Fisher Scientific, Bio-Rad, Liofilchem S r l, Pfizer Inc.
3. What are the main segments of the Antimicrobial Resistance Surveillance Market?
The market segments include Solution, Application, End-User.
4. Can you provide details about the market size?
The market size is estimated to be USD 5.90 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Infections Caused by Drug-resistance Microbes; Rising Initiatives by Governments to Tackle Infectious Diseases; Emerging of Multi-Drug Resistance Due to Drug Abuse.
6. What are the notable trends driving market growth?
The Clinical Diagnostics Under Application Segment is Expected to Hold a Significant Share in the Market.
7. Are there any restraints impacting market growth?
Higher Costs of Antimicrobial Resistance Surveillance systems and kits.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Antimicrobial Resistance Surveillance Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Antimicrobial Resistance Surveillance Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Antimicrobial Resistance Surveillance Market?
To stay informed about further developments, trends, and reports in the Antimicrobial Resistance Surveillance Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence